THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 1 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $617,425 | -16.7% | 71,620 | +0.0% | 0.00% | – |
| Q2 2023 | $740,970 | -52.4% | 71,604 | +66.5% | 0.00% | -100.0% |
| Q3 2016 | $1,558,000 | +59.6% | 43,018 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $976,000 | +19.5% | 43,018 | -1.1% | 0.00% | – |
| Q1 2016 | $817,000 | +14.6% | 43,492 | -0.1% | 0.00% | – |
| Q4 2015 | $713,000 | +176.4% | 43,522 | +85.1% | 0.00% | – |
| Q3 2015 | $258,000 | -19.4% | 23,518 | -4.4% | 0.00% | – |
| Q2 2015 | $320,000 | -36.6% | 24,606 | -15.4% | 0.00% | – |
| Q1 2015 | $505,000 | +16.4% | 29,078 | -0.1% | 0.00% | – |
| Q4 2014 | $434,000 | -35.3% | 29,105 | -0.1% | 0.00% | – |
| Q3 2014 | $671,000 | -27.8% | 29,120 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $929,000 | – | 29,120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,269,584 | $69,497,223,000 | 12.98% |
| Newtyn Management, LLC | 1,375,000 | $13,145,000 | 3.15% |
| Chescapmanager LLC | 1,166,574 | $11,152,000 | 1.51% |
| Baupost Group | 13,643,333 | $130,430,000 | 1.40% |
| Weiss Asset Management LP | 5,412,487 | $51,743,000 | 1.07% |
| CM Management, LLC | 120,000 | $1,147,000 | 0.96% |
| Orbimed Advisors | 3,254,713 | $31,115,000 | 0.50% |
| King Wealth Management Group | 122,000 | $1,166,000 | 0.23% |
| Woodline Partners LP | 1,326,653 | $12,683,000 | 0.21% |
| PDT Partners, LLC | 192,701 | $1,842,000 | 0.16% |